---
figid: PMC5923370__cancers-10-00115-g003
figtitle: Summary of discussed cancer-relevant pathways that activate YAP and TAZ
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5923370
filename: cancers-10-00115-g003.jpg
figlink: /pmc/articles/PMC5923370/figure/cancers-10-00115-f003/
number: F3
caption: Summary of discussed cancer-relevant pathways that activate YAP and TAZ.
  Depicted are several pathways that activate YAP and TAZ (black boxes/text) along
  with an indication of how each pathway is altered in cancer (red boxes/text). YAP/TAZ
  target genes implicated in cancer growth and progression (purple boxes/text) are
  also shown. Examples of existing drugs that target these pathways or are given (blue
  boxes/text).
papertitle: YAP/TAZ Activation as a Target for Treating Metastatic Cancer.
reftext: Janine S. A. Warren, et al. Cancers (Basel). 2018 Apr;10(4):115.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9077372
figid_alias: PMC5923370__F3
figtype: Figure
redirect_from: /figures/PMC5923370__F3
ndex: 54852ac7-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5923370__cancers-10-00115-g003.html
  '@type': Dataset
  description: Summary of discussed cancer-relevant pathways that activate YAP and
    TAZ. Depicted are several pathways that activate YAP and TAZ (black boxes/text)
    along with an indication of how each pathway is altered in cancer (red boxes/text).
    YAP/TAZ target genes implicated in cancer growth and progression (purple boxes/text)
    are also shown. Examples of existing drugs that target these pathways or are given
    (blue boxes/text).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - TGFB1
  - TGFB2
  - TGFB3
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TGFA
  - EGF
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - CTNNB1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - YAP1
  - TAFAZZIN
  - WWTR1
  - CCN2
  - AXL
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - BMP4
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - ALDH1A1
  - ALDH1A2
  - ALDH1A3
  - ALDH2
  - ALDH3A1
  - ALDH3A2
  - ALDH3B1
  - ALDH5A1
  - ALDH7A1
  - ALDH9A1
  - ARHGAP29
  - HMMR
  - SRC
  - FGR
  - FYN
  - YES1
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - ROCK1
  - ROCK2
  - PTK2
  - SF1126
  - Siomycin A
  - S765834
  - Porphyrins
  - Imatinib
  - Nilotinib
  - Blebbistatin
  - Dasatinib
  - Saracatinib
  - CCG-1423
  - Rhosin
  - Bosutinib
---
